-
Brewers beat Rays 4-1 to capture first World Series title
-
Asian stock markets fluctuate after mixed tech results
-
Philippine island fights rising seas with nature, not concrete
-
Samsung logs record quarterly profits despite investor AI jitters
-
Bangladesh presses India before Ganges water treaty expires
-
Miami stumble to draw against Cincinnati despite Suarez strike
-
Trump accuses Alaska Democrats of fraud over same-name scandal
-
Bangladesh scrambling as Ganges water treaty to expire
-
Spain mourns after latest train tragedy kills 68
-
England in peril with Rugby League World Cup semi spots at stake
-
Trump's border: quiet, but few people are happy
-
Antonelli ready to rewrite the Formula One record books in Mexico
-
Australian defence chief says China military buildup creating 'pressure' in SE Asia
-
EU, Canada to build 'new chapter' in alliance at Montreal summit
-
No penalty practice? No problem for Man City in shoot-out win
-
Argentine football fan jailed for threats over Di Maria return
-
Microsoft beats expectations fueled by Azure cloud business
-
Liverpool beat Chelsea in League Cup shoot-out, Man City survive scare
-
Chelsea win as Bayern draw with Madrid in Women's Champions League
-
Inter leave it late again in Serie A as AC Milan, Juventus lose
-
Kane watches as Bayern cruise into German Cup last 16
-
Shares in Google owner Alphabet plummet on profit miss, ad slowdown
-
Bayern boss Kompany out of hospital after meningeal irritation
-
Putin hails Elon Musk as 'truly a genius'
-
Shares in Google owner Alphabet sink on profit miss, ad slowdown
-
US stocks eye big tech earnings as Fed holds rates steady
-
Chelsea win as Bayern and Madrid draw in Women's Champions League
-
US Fed holds interest rates steady despite 'too high' inflation
-
Made with munitions from the Falklands War, a 'Chalice of Peace' for the pope
-
Rwanda cannot be blamed for what happens in DR Congo, FM says
-
Pioneering US labor leader Dolores Huerta dies at 96
-
Inter leave it late again in Serie A as Bologna sink AC Milan
-
Italian PM slams 'shameful' release of alleged protest organiser
-
Bolsonaro's escape to the US: How it happened
-
Hollywood producer Kennedy to head LA28 Olympic ceremony plans
-
Russell calls on Scotland to 'kick on' and beat big teams
-
Djokovic wins Basel opener to boost ATP Finals bid
-
Airbus aims for record deliveries despite disappointing quarter
-
US Fed holds interest rates steady despite surging inflation
-
Cuba wins UN vote against US embargo with weakest backing in 30 years
-
Chiefs sign ex-Ravens kicker suspended over sex allegations
-
Real Madrid, La Liga apology over Mbappe shows power of Chinese market
-
Inglis and Carey put Australia in command of South Africa decider
-
From Gaza to Ramallah, Palestinians see little hope in Israeli vote
-
92-year-old US judge handling Maduro case dies
-
US labor leader Dolores Huerta dead: family
-
Perez extends Cadillac deal to 2029
-
Investors turn cautious ahead of tech results, Fed update on rates
-
Arab Israelis proud of high election turnout, uncertain for future
-
'Cruise for life' strands passengers in Cambodia as operator goes bust
Costa Rican sloth antibiotics offer hope for human medicine
The fur of Costa Rican sloths appears to harbor antibiotic-producing bacteria that scientists hope may hold a solution to the growing problem of "superbugs" resistant to humanity's dwindling arsenal of drugs.
Sloth fur, research has found, hosts bustling communities of insects, algae, fungi and bacteria, among other microbes, some of which could pose disease risk.
Yet, experts say, the famously slow-moving mammals appear to be surprisingly infection-proof.
"If you look at the sloth's fur, you see movement: you see moths, you see different types of insects... a very extensive habitat," Max Chavarria, a researcher at the University of Costa Rica, told AFP.
"Obviously when there is co-existence of many types of organisms, there must also be systems that control them," he said.
Chavarria and a team took fur samples from Costa Rican two- and three-toed sloths to examine what that control system could be.
They found the possible existence of antibiotic-producing bacteria that "makes it possible to control the proliferation of potentially pathogenic bacteria... or inhibit other competitors" such as fungi, according to a study published in the journal Environmental Microbiology.
- 'No infection' -
The sloth is a national symbol in laid back Costa Rica, and a major tourist attraction for the Central American country.
Both the two-toed (Choloepus Hoffmanni) and three-toed (Bradypus variegatus) sloth species have seen their populations decline, according to the International Union for the Conservation of Nature's Red List of Threatened Species.
They live in the canopies of trees in the jungle on the Caribbean coast, where the climate is hot and humid.
American Judy Avey runs a sanctuary in the balmy jungle to care for sloths injured after coming into contact with humans or other animals.
She treats and rehabilitates the creatures with a view to releasing them back into the wild.
"We've never received a sloth that has been sick, that has a disease or has an illness," she told AFP.
"We've received sloths that had been burned by power lines and their entire arm is just destroyed... and there's no infection.
"I think maybe in the 30 years (we've been open), we've seen five animals that have come in with an infected injury. So that tells us there's something going on in their... bodily ecosystem."
Avey, who established the sanctuary with her late Costa Rican husband, Luis Arroyo, had never even heard of a sloth back home in Alaska.
Since receiving her first sloth, whom she named "Buttercup," in 1992, she has cared for around 1,000 animals.
- Penicillin inspiration -
Researcher Chavarria took fur samples taken from sloths at the sanctuary to examine in his laboratory.
He began his research in 2020, and has already pinpointed 20 "candidate" microorganisms waiting to be named.
But he said there is a long road ahead in determining whether the sloth compounds could be useful to humans.
"Before thinking about an application in human health, it's important to first understand... what type of molecules are involved," said Chavarria.
An example of this is penicillin, discovered in 1928 by British scientist Alexander Fleming, who discovered that a fungal contamination of a laboratory culture appeared to kill a disease-causing bacteria.
His discovery of the world's first bacteria-killer, or antibiotic, earned him the 1945 Nobel Prize in medicine.
However, microbial resistance to antibiotics has been a growing problem, meaning some medicines no longer work to fight the infections they were designed to treat.
Antimicrobial resistance is a natural phenomenon, but the overuse and misuse of antibiotics in humans, animals and plants has made the problem worse.
The World Health Organization estimates that by 2050, resistance to antibiotics could cause 10 million deaths a year.
"Projects like ours can contribute to finding... new molecules that can, in the medium or long term, be used in this battle against antibiotic resistance," said Chavarria.
F.Müller--BTB